Radiofrequency renal denervation (RF RDN) is recognized as an adjunct therapy for hypertension. This study evaluated the cost-effectiveness of RF RDN for the Taiwanese healthcare system using results from the SPYRAL HTN-ON MED randomized, sham-controlled trial.
